Fibrinolytic and Inflammatory Markers for Arterial Occlusion: The Evolving Epidemiology of Thrombosis and Hemostasis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Thrombosis and Haemostasis

• Publication date

  1997-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0038-1657500PMID 9198127
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Arterial and venous thrombosis is not associated with the 4G/5G polymorphism in the promoter of the plasminogen activator inhibitor gene in a large cohort of US men.

  1997cited by this paper
• C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study

  1996cited by this paper
• Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities.

  1996cited by this paper
• Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.

  1996cited by this paper
• Adhesion molecules--Part II: Blood vessels and blood cells.

  1996cited by this paper
• Alu-repeat polymorphism in the tissue-type plasminogen activator (t-PA) gene, t-PA levels and risk of familial myocardial infarction (MI)

  1996cited by this paper
• A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

  1996cited by this paper
• Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy.

  1996cited by this paper
• Distribution and frequency of a polymorphicAlu insertion at the plasminogen activator locus in humans

  1996cited by this paper
• Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment.

  1996cited by this paper
• Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

  1996cited by this paper
• Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction.

  1995cited by this paper
• Relationship between alcohol intake and tissue plasminogen activator antigen and other haemostatic factors in the general population

  1995cited by this paper
• Fibrinogen and Cardiovascular Risk

  1995cited by this paper
• Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study. Atherosclerosis Risk in Communities Study.

  1995cited by this paper
• Polymorphism of the blood clot lysis enzyme tissue-type plasminogen activator is associated with myocardial infarction

  1995cited by this paper
• The 4G/5G Genetic Polymorphism in the Promoter of the Plasminogen Activator Inhibitor-1 (PAI-1) Gene Is Associated with Differences in Plasma PAI-1 Activity but not with Risk of Myocardial Infarction in the ECTIM Study

  1995cited by this paper
• Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors

  1995cited by this paper
• Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.

  1995cited by this paper
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  1995cited by this paper
• Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.

  1995cited by this paper
• A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

  1995cited by this paper
• Serum total homocysteine and coronary heart disease.

  1995cited by this paper
• Serum Amyloid a Protein in Patients with Acute Myocardial Infarction

  1995cited by this paper
• Association of moderate alcohol consumption and plasma concentration of endogenous tissue-type plasminogen activator.

  1994cited by this paper
• Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men.

  1994cited by this paper
• Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS)

  1994cited by this paper
• Factor-VII activity and ischaemic heart disease: fatal and non-fatal events.

  1994cited by this paper
• Resistance to activated protein C as a basis for venous thrombosis.

  1994cited by this paper
• Relation of Helicobacter pylori infection and coronary heart disease.

  1994cited by this paper
• Prospective study of endogenous tissue plasminogen activator and risk of stroke.

  1994cited by this paper
• Macrophage Infiltration in Acute Coronary Syndromes: Implications for Plaque Rupture

  1994cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• Lipoprotein(a) levels and risk of coronary heart disease in men. The lipid Research Clinics Coronary Primary Prevention Trial.

  1994cited by this paper
• Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based study.

  1994cited by this paper
• Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction.

  1994cited by this paper
• Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.

  1993cited by this paper
• The pathogenesis of atherosclerosis: a perspective for the 1990s

  1993cited by this paper
• Stimulation of Plasminogen Activator Inhibitor In Vivo by Infusion of Angiotensin II Evidence of a Potential Interaction Between the Renin‐Angiotensin System and Fibrinolytic Function

  1993cited by this paper
• Predictive Value of Tissue Plasminogen Activator Mass Concentration on Long‐term Mortalit in Patients With Coronary Artery Disease A 7‐Year Follow‐up

  1993cited by this paper
• Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients. A case-control study. The PLAT Group.

  1993cited by this paper
• A prospective study of lipoprotein(a) and the risk of myocardial infarction.

  1993cited by this paper
• Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease.

  1993cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993influential reference
• The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

  1993cited by this paper
• Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.

  1993influential reference
• Haemostatic Variables and Menopausal Status: Influence of Hormone Replacement Therapy

  1993cited by this paper
• Inflammation in Acute Coronary Syndromes

  1993cited by this paper
• Prothrombin Activation Fragment 1 + 2 and Thrombin Antithrombin III Complexes in Patients with Angina Pectoris: Relation to the Presence and Severity of Coronary Atherosclerosis

  1993cited by this paper
• Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the Bezafibrate Infarction Prevention Trial).

  1993cited by this paper
• Serum C-reactive protein and infarct size in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy.

  1993cited by this paper
• Association of Hormone-Replacement Therapy With Various Cardiovascular Risk Factors in Postmenopausal Women

  1993cited by this paper
• Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators.

  1993cited by this paper
• Fibrinogen as a cardiovascular risk factor: a meta-analysis

  1993cited by this paper
• Direct Effects of Gemfibrozil on the Fibrinolytic System: Diminution of Synthesis of Plasminogen Activator Inhibitor Type 1

  1992cited by this paper
• Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators.

  1992cited by this paper
• Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions.

  1992cited by this paper
• Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study

  1992cited by this paper
• C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo.

  1992cited by this paper
• Hemostatic factors according to menopausal status and use of hormone replacement therapy.

  1992cited by this paper
• Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease.

  1992cited by this paper
• von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

  1992cited by this paper
• A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians.

  1992cited by this paper
• The possible role of cytomegalovirus in atherogenesis.

  1991cited by this paper
• [Role of macrophages in atherogenesis].

  1991cited by this paper
• von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

  1991cited by this paper
• Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.

  1991cited by this paper
• Blood Platelet Count and Function Are Related to Total and Cardiovascular Death in Apparently Healthy Men

  1991cited by this paper
• Influence of platelet size on outcome after myocardial infarction.

  1991cited by this paper
• Elevation of C-reactive protein in "active" coronary artery disease.

  1990cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Possible role of cytomegalovirus in atherogenesis.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Platelet hyperreactivity and prognosis in survivors of myocardial infarction.

  1990cited by this paper
• Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Fibrinogen and risk of cardiovascular disease. The Framingham Study.

  1987cited by this paper
• Fibrinogen, cigarette smoking, and risk of cardiovascular disease: insights from the Framingham Study.

  1987cited by this paper
• INCREASED PLASMA CONCENTRATION OF CROSSLINKED FIBRIN POLYMERS IN ACUTE MYOCARDIAL INFARCTION

  1987cited by this paper
• Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects.

  1986cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper

• Association of C677T MTHFR and G20210A FII prothrombin polymorphisms with susceptibility to myocardial infarction.

  2016cites this paper
• Evaluation of d-dimer and crp in cases of atherosclerosis (cad)

  2015cites this paper
• The significance of D-dimer levels and an elevated ESR in association with a hypercoagulable state in patients with cerebrovascular disease

  2014cites this paper
• Antiplatelet therapies: aspirin at the heart of new directions.

  2014cites this paper
• Effect of Different Vegetable Fats on Lipid Profile and Risk of Atherosclerosis in Rats

  2013cites this paper
• Aus der Klinik für Allgemeine und Interventionelle Kardiologie des Universitären

  2013cites this paper
• Impact of Periodontal Infection on Systemic Health

  2012cites this paper
• Marcadores inflamatórios de instabilidade da placa aterosclerótica coronária : caraterização e potencial utilização clínica

  2012cites this paper
• Inflammatory and Infectious Basis of Atherosclerosis

  2012cites this paper
• Hemostatic cardiovascular risk factors, common carotid–intima medial thickness and peripheral arterial disease in South Asians and African Caribbeans: a substudy to the Ethnic‐Echocardiographic Heart of England Screening (E‐ECHOES) Study

  2011cites this paper
• Metabolic effects of fructose and the worldwide increase in obesity.

  2010cites this paper
• Peripheral Artery Disease and Angiogenesis: A Link Between Angiogenesis and Atherothrombosis

  2010cites this paper
• Alteration of cardiac cytochrome P450-mediated arachidonic acid metabolism in response to lipopolysaccharide-induced acute systemic inflammation.

  2010cites this paper
• Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men

  2010cites this paper
• Peripheral arterial disease and Virchow’s triad

  2009cites this paper
• Über die vasoaktiven Eigenschaften von Clopidogrel im Vergleich zu Acetylsalicylsäure bei Patienten mit ischämischer Kardiomyopathie

  2009cites this paper
• Cardiovascular disease, diabetes and established risk factors among populations of sub-Saharan African descent in Europe: a literature review

  2009cites this paper
• Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease.

  2008cites this paper
• Detrimental Impact of Trans Fats on Human Health: Stearic Acid-Rich Fats as Possible Substitutes.

  2008cites this paper
• Factor VLeiden and Prothrombin G20210A Gene Polymorphisms in Patients with Coronary Artery Disease

  2008cites this paper
• Increased High Sensitive CRP Level and Its Significance in Pathogenesis of Slow Coronary Flow

  2007cites this paper
• Identifying Cardiovascular Risk Factors in a Patient Population With Coronary Artery Ectasia

  2007cites this paper
• Long-term prognostic value of protein C activity, erythrocyte aggregation and membrane fluidity in transmural myocardial infarction

  2005cites this paper
• Fatty acids and atherosclerotic risk.

  2005cites this paper
• Biomarkers of Cardiac Injury: An Update

  2005cites this paper
• Periodontal health improves systemic inflammatory and haemostatic status in subjects with coronary heart disease.

  2005cites this paper
• Erythrocyte sedimentation rate as a marker of inflammation and ongoing coagulation in stroke and transient ischaemic attack.

  2005cites this paper
• Association study of the thrombomodulin -33G>A polymorphism with coronary artery disease and myocardial infarction in Chinese Han population.

  2005cites this paper
• Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects.

  2005cites this paper
• The Fibrinolysis System: Regulation of Activity and Physiologic Functions of Its Main Components

  2004cites this paper
• Distinctive effects of red wine and diet on haemostatic cardiovascular risk factors.

  2004cites this paper
• Poor oral health is associated with coronary heart disease and elevated systemic inflammatory and haemostatic factors.

  2004cites this paper
• Foodstate vitamin C complex may beneficially affect haemostasis and fibrin network structure in hyperlipidaemic patients

  2004cites this paper
• Haemostatic Cardiovascular Risk Factors: Differential Effects of Red Wine and Diet on Healthy Young

  2003cites this paper
• Novos Fatores de Risco Cardiovascular

  2003cites this paper
• Fibrinogen kao faktor rizika za ishemijsku bolest srca

  2003cites this paper
• Fibrinolytic response to venous occlusion is decreased in patients after Kawasaki disease

  2003cites this paper
• Magnesium in arterial thrombosis, ischaemia-reperfusion injury, and atherosclerosis--evidence from experimental studies.

  2003cites this paper
• New definitions in cardiovascular risk management: is it time for angiotensin II receptor blockers to become first-line medication?

  2003cites this paper
• Abstracts of the NIH-FDA Conference “Biomarkers and Surrogate Endpoints: Advancing Clinical Research and Applications”

  2002cites this paper
• Association between plasma levels of the soluble CD14 receptor of lipopolysaccharide and the C(-260)→T polymorphism in the promoter of the CD14 gene and coronary artery disease: investigations in a large case-control study

  2002cites this paper
• Angina: identifying and managing the patient at risk

  2002cites this paper
• Increase of arterial thrombosis parameters in chronic Helicobacter pylori infection in mice.

  2002cites this paper
• Association of factor VII levels with inflammatory parameters in hypercholesterolemic patients.

  2002cites this paper
• The Effect of Ischemia on Local Changes in Thrombomodulin and Molecular Markers during Aortic Cross Clamp

  2001cites this paper
• C-Reactive Protein, Fibrin D-Dimer, and Incident Ischemic Heart Disease in the Speedwell Study: Are Inflammation and Fibrin Turnover Linked in Pathogenesis?

  2001cites this paper
• G20210A Prothrombin Gene Polymorphism and Prothrombin Activity in Subjects With or Without Angiographically Documented Coronary Artery Disease

  2001influential citation
• Inflammation and Coronary Heart Disease: An Overview

  2001cites this paper
• Inflammatory pathways in atherosclerosis and acute coronary syndromes.

  2001cites this paper
• Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia.

  2001cites this paper
• Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings.

  2001cites this paper
• Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors

  2001cites this paper
• Virchow's triad revisited: the importance of soluble coagulation factors, the endothelium, and platelets.

  2001cites this paper
• Increased activation of protein C, but lower plasma levels of free, activated protein C in uraemic patients: relationship with systemic inflammation and haemostatic activation

  2001cites this paper
• Genetics of Arterial Thrombosis

  2001cites this paper
• C-reactive Protein — a Prognostic Marker of Inflammation in Atherothrombosis

  2001cites this paper
• Original Communication Complementary effects of Mediterranean diet and moderate red wine intake on haemostatic cardiovascular risk factors

  2001cites this paper
• Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT).

  2000cites this paper
• Serum amyloid A predicts early mortality in acute coronary syndromes: A TIMI 11A substudy.

  2000cites this paper
• The G20210A prothrombin mutation and the Physicians' Health Study.

  2000cites this paper
• Oral Contraceptives, Hormone Replacement Therapy and Haemostasis

  2000cites this paper
• Concepts in acute coronary syndromes.

  2000cites this paper
• Relationship between fibrinolytic and metabolic variables: a study in patients attending a lipid clinic

  2000cites this paper
• Increase of adhesion molecules, fibrinogen, type‐1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement

  2000cites this paper
• Novel risk factors for coronary heart disease: emerging connections.

  2000cites this paper
• Endothelial dysfunction : mechanisms and reversal in insulin resistance and diabetes mellitus

  2000cites this paper
• Increased plasma fibrinogen level and future risk of coronary artery disease after repair of abdominal aortic aneurysm.

  2000cites this paper
• Cardiac markers for assessing the acute coronary syndromes. A focus on cardiac troponins.

  2000cites this paper
• Concepts in Acute Coronary Syndromes

  2000cites this paper
• Effects of Fluvastatin and Bezafibrate Combination on Plasma Fibrinogen, t-plasminogen Activator Inhibitor and C Reactive Protein Levels in Coronary Artery Disease Patients with Mixed Hyperlipidaemia (FACT Study)

  2000cites this paper
• Engineered recombinant factor VII Q217 variants with altered inhibitor specificities.

  1999cites this paper
• Activated Protein C Resistance, Factor V Leiden, and Venous Thromboembolism

  1999cites this paper
• Einfluß der Plasma-Fettsäurezusammen-setzung auf das atherogene Entzündungsprofil bei gesunden Erwachsenen

  1999cites this paper
• The activation of plasminogen activator inhibitor-1 expression by IL-1beta is attenuated by estrogen in hepatoblastoma HepG2 cells expressing estrogen receptor alpha.

  1999cites this paper
• Vegetarians and Cardiovascular Risk Factors: Hemostasis, Inflammatory Markers and Plasma Homocysteine

  1999cites this paper
• Haemostatic factors and risk of coronary heart disease.

  1999cites this paper
• [Modifications of the hemostatic balance during estrogen treatments: menopause and its treatment].

  1999cites this paper
• The Activation of Plasminogen Activator Inhibitor-1 Expression by IL-1β Is Attenuated by Estrogen in Hepatoblastoma HepG2 Cells Expressing Estrogen Receptor α

  1999cites this paper
• Endothelial cell damage and the development or progression of atherosclerosis.

  1999cites this paper
• Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis.

  1999cites this paper
• Contribution of factor VII, fibrinogen and fibrinolytic components to the risk of ischaemic cardiovascular disease: their genetic determinants

  1998cites this paper
• Fibrinogen as a factor of thrombosis: experimental study.

  1998cites this paper
• Fibrinogen as a Factor of Thrombosis: Experimental Study

  1998cites this paper
• Biochemical markers in the diagnosis of coronary artery disease.

  1998cites this paper
• Sulfonylureas and Cardiovascular Mortality in Diabetes : A Class Effect ?

  1998cites this paper
• No Association between the 20210 G/A Prothrombin Gene Mutation and Premature Coronary Artery Disease

  1998cites this paper
• Fibrinogen Plasma Levels in an Apparently Healthy General Population – Relation to Environmental and Genetic Determinants

  1998cites this paper
• Antihypertensive drug treatment and fibrinolytic function.

  1998cites this paper
• Nontraditional Coronary Risk Factors and Vascular Biology: The Frontiers of Preventive Cardiology

  1998cites this paper
• Factor V Leiden and thromboembolism.

  1998cites this paper
• Prothrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men.

  1998cites this paper
• The endothelium in atherothrombotic disease: assessment of function, mechanisms and clinical implications.

  1998cites this paper
• Unfractionated heparin dosing in the FRIC study.

  1998cites this paper
• Specificity of Haemostasis Abnormalities for Vascular Phenotypes

  1998cites this paper
• Unfractionated Heparin Dosing in the FRIC Study

  1998cites this paper
• Antihypertensive drug treatment and fibrinolytic function.

  1998cites this paper
• Etiopathogenesis of cardiovascular disease: hemostasis, thrombosis, and vascular medicine.

  1998cites this paper
• Intrinsic fibrinolytic capacity and systemic inflammation: novel risk factors for arterial thrombotic disease.

  1997cites this paper
• Fibrinolysis and thrombosis.

  1994cites this paper